Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study
- PMID: 30106959
- PMCID: PMC6091948
- DOI: 10.1371/journal.pone.0201750
Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study
Abstract
Introduction: Phototype has been associated with an increased risk of prostate cancer, and it is yet unknown if it is related to other hormone-dependent cancers, such as breast cancer or whether this association could be considered causal.
Methods: We examined the association between the phototype and breast and prostate cancers using a Mendelian randomization analysis. We studied 1,738 incident cases of breast cancer and another 817 cases of prostate cancer. To perform a Mendelian randomization analysis on the phototype-cancer relationship, a genetic pigmentation score was required that met the following criteria: (1) the genetic pigmentation score was associated with phototype in controls; (2) the genetic pigmentation score was not associated with confounders in the relationship between phototype and cancer, and (3) the genetic pigmentation score was associated with cancer only through its association with phototype. Once this genetic score is available, the association between genetic pigmentation score and cancer can be identified as the association between phototype and cancer.
Results: The association between the genetic pigmentation score and phototype in controls showed that a higher genetic pigmentation score was associated with fair skin, blond hair, blue eyes and the presence of freckles. Applying the Mendelian randomization analysis, we verified that there was no association between the genetic pigmentation score and cancers of the breast and prostate.
Conclusions: Phototype is not associated with breast or prostate cancer.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study).Environ Health Perspect. 2018 Apr 23;126(4):047011. doi: 10.1289/EHP1837. Environ Health Perspect. 2018. PMID: 29687979 Free PMC article.
-
Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study.PLoS Genet. 2022 Jan 21;18(1):e1009887. doi: 10.1371/journal.pgen.1009887. eCollection 2022 Jan. PLoS Genet. 2022. PMID: 35061662 Free PMC article.
-
Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.BMC Med. 2016 Apr 4;14:66. doi: 10.1186/s12916-016-0602-x. BMC Med. 2016. PMID: 27044414 Free PMC article.
-
[Application status and prospect of Mendelian randomization analysis in the study of prostate cancer pathogenesis].Zhonghua Nan Ke Xue. 2023 Jul;29(7):654-659. Zhonghua Nan Ke Xue. 2023. PMID: 38619416 Review. Chinese.
-
Access and barriers to genomic classifiers for breast cancer and prostate cancer in India.Int J Cancer. 2024 Apr 15;154(8):1335-1339. doi: 10.1002/ijc.34784. Epub 2023 Nov 14. Int J Cancer. 2024. PMID: 37962056 Free PMC article. Review.
Cited by
-
The silent variants of pituitary tumors: demographic, radiological and molecular characteristics.J Endocrinol Invest. 2021 Aug;44(8):1637-1648. doi: 10.1007/s40618-020-01468-2. Epub 2021 Jan 21. J Endocrinol Invest. 2021. PMID: 33476035
-
Skin Phototype and Disease: A Comprehensive Genetic Approach to Pigmentary Traits Pleiotropy Using PRS in the GCAT Cohort.Genes (Basel). 2023 Jan 5;14(1):149. doi: 10.3390/genes14010149. Genes (Basel). 2023. PMID: 36672889 Free PMC article.
-
Systematic review of Mendelian randomization studies on risk of cancer.BMC Med. 2022 Feb 2;20(1):41. doi: 10.1186/s12916-022-02246-y. BMC Med. 2022. PMID: 35105367 Free PMC article.
References
-
- Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V, et al. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2016;37: 12941–12957. 10.1007/s13277-016-5168-x - DOI - PubMed
-
- Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016;49: 65–76. 10.1016/j.ctrv.2016.07.006 - DOI - PubMed
-
- Hankinson S, Tamimi R, Hunter D. Breast Cancer Textbook of Cancer Epidemiology. Second Edition New York: Oxford University Press; 2008. pp. 403–445.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous